These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava ( Wang Y; Su C; Zhang B; Niu Y; Ren R; Zhao X; Yang L; Zhang W; Ma X Evid Based Complement Alternat Med; 2021; 2021():6851798. PubMed ID: 34471418 [TBL] [Abstract][Full Text] [Related]
25. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology. Showman AF; Baker JD; Linares C; Naeole CK; Borris R; Johnston E; Konanui J; Turner H Fitoterapia; 2015 Jan; 100():56-67. PubMed ID: 25464054 [TBL] [Abstract][Full Text] [Related]
26. Kava as a Clinical Nutrient: Promises and Challenges. Bian T; Corral P; Wang Y; Botello J; Kingston R; Daniels T; Salloum RG; Johnston E; Huo Z; Lu J; Liu AC; Xing C Nutrients; 2020 Oct; 12(10):. PubMed ID: 33027883 [TBL] [Abstract][Full Text] [Related]
27. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Weiss J; Sauer A; Frank A; Unger M Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732 [TBL] [Abstract][Full Text] [Related]
28. Investigating volatiles as the secondary metabolome of Piper methysticum from root powder and water extracts using comprehensive two-dimensional gas chromatography. Cheung C; Baker JD; Byrne JM; Perrault KA J Ethnopharmacol; 2022 Aug; 294():115346. PubMed ID: 35533912 [TBL] [Abstract][Full Text] [Related]
29. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum. Tugcu G; Kırmızıbekmez H; Aydın A Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561 [TBL] [Abstract][Full Text] [Related]
31. Composition and biological activity of traditional and commercial kava extracts. Côté CS; Kor C; Cohen J; Auclair K Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821 [TBL] [Abstract][Full Text] [Related]
33. Differential regulation of calcium signalling pathways by components of Piper methysticum ('Awa). Shimoda LM; Showman A; Baker JD; Lange I; Koomoa DL; Stokes AJ; Borris RP; Turner H Phytother Res; 2015 Apr; 29(4):582-90. PubMed ID: 25640812 [TBL] [Abstract][Full Text] [Related]
36. Rapid detection and validated quantification of psychoactive compounds in complex plant matrices by direct analysis in real time-high resolution mass spectrometry - Application to "Kava" psychoactive pepper products. Chambers MI; Osborne AM; Musah RA Rapid Commun Mass Spectrom; 2019 Dec; 33(24):1915-1925. PubMed ID: 31323704 [TBL] [Abstract][Full Text] [Related]
37. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro. Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848 [TBL] [Abstract][Full Text] [Related]
38. Analysis of kavalactones from Piper methysticum (kava-kava). Bilia AR; Scalise L; Bergonzi MC; Vincieri FF J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499 [TBL] [Abstract][Full Text] [Related]
39. Constituents in kava extracts potentially involved in hepatotoxicity: a review. Olsen LR; Grillo MP; Skonberg C Chem Res Toxicol; 2011 Jul; 24(7):992-1002. PubMed ID: 21506562 [TBL] [Abstract][Full Text] [Related]